WANG LAI (Global Head of R&D) received a stock award from BEONE MEDICINES LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/10/2026ACC: 0001852291-26-000003
Officer· Global Head of R&D
Since Apr 2021
+167.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
167.63K acquired
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+112.61K
Price / share
—
Trade value
—
% of position
7.8%
3/6/2026
1.45M→1.56M
Ordinary Shares
Direct
Shares
+55.03K
Price / share
—
Trade value
—
% of position
3.5%
3/6/2026
1.56M→1.62M
Total
Net shares
+167.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/6/2026 | A · Award | +112.61K | — | — | 7.8% | 1.45M | 1.56M |
| Ordinary Shares Direct | 3/6/2026 | A · Award | +55.03K | — | — | 3.5% | 1.56M | 1.62M |
| Total | +167.63K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
RMB Shares
IndirectShares owned0.00
Ordinary Shares
IndirectShares owned601.97K
Total
601.97K indirect601.97K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| RMB Shares | 0.00 | Indirect |
| Ordinary Shares | 601.97K | Indirect |
| Total | 601.97K | 601.97K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported